Literature DB >> 28844864

The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin-Remodeling Complexes.

Ryan J Conrad1, Parinaz Fozouni2, Sean Thomas3, Hendrik Sy3, Qiang Zhang4, Ming-Ming Zhou4, Melanie Ott5.   

Abstract

BET proteins commonly activate cellular gene expression, yet inhibiting their recruitment paradoxically reactivates latent HIV-1 transcription. Here we identify the short isoform of BET family member BRD4 (BRD4S) as a corepressor of HIV-1 transcription. We found that BRD4S was enriched in chromatin fractions of latently infected T cells, and it was more rapidly displaced from chromatin upon BET inhibition than the long isoform. BET inhibition induced marked nucleosome remodeling at the latent HIV-1 promoter, which was dependent on the activity of BRG1-associated factors (BAF), an SWI/SNF chromatin-remodeling complex with known repressive functions in HIV-1 transcription. BRD4S directly bound BRG1, a catalytic subunit of BAF, via its bromodomain and extraterminal (ET) domain, and this isoform was necessary for BRG1 recruitment to latent HIV-1 chromatin. Using chromatin immunoprecipitation sequencing (ChIP-seq) combined with assay for transposase-accessible chromatin coupled to high-throughput sequencing (ATAC-seq) data, we found that the latent HIV-1 promoter phenotypically resembles endogenous long terminal repeat (LTR) sequences, pointing to a select role of BRD4S-BRG1 complexes in genomic silencing of invasive retroelements.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BET protein; BRD4; BRG1; HIV; JQ1; LTR; SWI/SNF; bromodomain; chromatin; latency

Mesh:

Substances:

Year:  2017        PMID: 28844864      PMCID: PMC5610089          DOI: 10.1016/j.molcel.2017.07.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  70 in total

1.  BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.

Authors:  Camellia Banerjee; Nancie Archin; Daniel Michaels; Anna C Belkina; Gerald V Denis; James Bradner; Paola Sebastiani; David M Margolis; Monty Montano
Journal:  J Leukoc Biol       Date:  2012-07-16       Impact factor: 4.962

2.  The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter.

Authors:  Tokameh Mahmoudi; Maribel Parra; Robert G J Vries; Steven E Kauder; C Peter Verrijzer; Melanie Ott; Eric Verdin
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

3.  L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells.

Authors:  Nuo Yang; Haig H Kazazian
Journal:  Nat Struct Mol Biol       Date:  2006-08-27       Impact factor: 15.369

Review 4.  The control of HIV transcription: keeping RNA polymerase II on track.

Authors:  Melanie Ott; Matthias Geyer; Qiang Zhou
Journal:  Cell Host Microbe       Date:  2011-11-17       Impact factor: 21.023

5.  Polycomb complexes act redundantly to repress genomic repeats and genes.

Authors:  Martin Leeb; Diego Pasini; Maria Novatchkova; Markus Jaritz; Kristian Helin; Anton Wutz
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

6.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

7.  Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein.

Authors:  Koen Bartholomeeusen; Yanhui Xiang; Koh Fujinaga; B Matija Peterlin
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

8.  Genome-wide localization of protein-DNA binding and histone modification by a Bayesian change-point method with ChIP-seq data.

Authors:  Haipeng Xing; Yifan Mo; Will Liao; Michael Q Zhang
Journal:  PLoS Comput Biol       Date:  2012-07-26       Impact factor: 4.475

9.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

10.  Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes.

Authors:  Ross C Larue; Matthew R Plumb; Brandon L Crowe; Nikoloz Shkriabai; Amit Sharma; Julia DiFiore; Nirav Malani; Sriram S Aiyer; Monica J Roth; Frederic D Bushman; Mark P Foster; Mamuka Kvaratskhelia
Journal:  Nucleic Acids Res       Date:  2014-02-11       Impact factor: 16.971

View more
  49 in total

1.  A BAF'ling Approach to Curing HIV.

Authors:  Sakshi Tomar; Ibraheem Ali; Melanie Ott
Journal:  Cell Chem Biol       Date:  2018-12-20       Impact factor: 8.116

2.  BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC.

Authors:  Brandon Leonard; Toni M Brand; Rachel A O'Keefe; Eliot D Lee; Yan Zeng; Jacquelyn D Kemmer; Hua Li; Jennifer R Grandis; Neil E Bhola
Journal:  Cancer Res       Date:  2018-05-23       Impact factor: 12.701

3.  Chemical Inhibitors of a Selective SWI/SNF Function Synergize with ATR Inhibition in Cancer Cell Killing.

Authors:  Emma J Chory; Jacob G Kirkland; Chiung-Ying Chang; Vincent D D'Andrea; Sai Gourisankar; Emily C Dykhuizen; Gerald R Crabtree
Journal:  ACS Chem Biol       Date:  2020-05-27       Impact factor: 5.100

4.  Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal.

Authors:  Christine A Marian; Mateusz Stoszko; Lili Wang; Matthew W Leighty; Elisa de Crignis; Chad A Maschinot; Jovylyn Gatchalian; Benjamin C Carter; Basudev Chowdhury; Diana C Hargreaves; Jeremy R Duvall; Gerald R Crabtree; Tokameh Mahmoudi; Emily C Dykhuizen
Journal:  Cell Chem Biol       Date:  2018-09-06       Impact factor: 8.116

5.  Opposing Functions of BRD4 Isoforms in Breast Cancer.

Authors:  Shwu-Yuan Wu; Chien-Fei Lee; Hsien-Tsung Lai; Cheng-Tai Yu; Ji-Eun Lee; Hao Zuo; Sophia Y Tsai; Ming-Jer Tsai; Kai Ge; Yihong Wan; Cheng-Ming Chiang
Journal:  Mol Cell       Date:  2020-05-23       Impact factor: 17.970

6.  Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.

Authors:  Matthew S Stratton; Rushita A Bagchi; Marina B Felisbino; Rachel A Hirsch; Harrison E Smith; Andrew S Riching; Blake Y Enyart; Keith A Koch; Maria A Cavasin; Michael Alexanian; Kunhua Song; Jun Qi; Madeleine E Lemieux; Deepak Srivastava; Maggie P Y Lam; Saptarsi M Haldar; Charles Y Lin; Timothy A McKinsey
Journal:  Circ Res       Date:  2019-08-14       Impact factor: 17.367

7.  Epigenetic Compound Screening Uncovers Small Molecules for Reactivation of Latent HIV-1.

Authors:  Ariane Zutz; Lin Chen; Franziska Sippl; Andreas Humpe; Christian Schölz
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

8.  Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV.

Authors:  Qingli Niu; Zhiqing Liu; Edrous Alamer; Xiuzhen Fan; Haiying Chen; Janice Endsley; Benjamin B Gelman; Bing Tian; Jerome H Kim; Nelson L Michael; Merlin L Robb; Jintanat Ananworanich; Jia Zhou; Haitao Hu
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

9.  BRD4S interacts with viral E2 protein to limit human papillomavirus late transcription.

Authors:  A Yigitliler; J Renner; C Simon; M Schneider; F Stubenrauch; T Iftner
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

10.  Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

Authors:  Aktan Alpsoy; Emily C Dykhuizen
Journal:  J Biol Chem       Date:  2018-01-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.